Y300-0171 Screening compound: N-(2,2-dimethyl-3,4-dihydro-2H-1-benzopyran-4-yl)-1-[(4-fluorophenyl)methyl]piperidine-4-carboxamide

Y300-0171 Screening compound: N-(2,2-dimethyl-3,4-dihydro-2H-1-benzopyran-4-yl)-1-[(4-fluorophenyl)methyl]piperidine-4-carboxamide
Y300-0171 Screening compound: N-(2,2-dimethyl-3,4-dihydro-2H-1-benzopyran-4-yl)-1-[(4-fluorophenyl)methyl]piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y300-0171
N-(2,2-dimethyl-3,4-dihydro-2H-1-benzopyran-4-yl)-1-[(4-fluorophenyl)methyl]piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y300-0171

Molecular Formula

C24H29FN2O2 (C24 H29 FN2 O2)

Compound Name

N-(2,2-dimethyl-3,4-dihydro-2H-1-benzopyran-4-yl)-1-[(4-fluorophenyl)methyl]piperidine-4-carboxamide

IUPAC name

N-(22-dimethyl-34-dihydro-2H-1-benzopyran-4-yl)-1-[(4-fluorophenyl)methyl]piperidine-4-carboxamide

SMILES

CC(C)(CC1NC(C2CCN(Cc(cc3)ccc3F)CC2)=O)Oc2c1cccc2

InChI

InChI=1S/C24H29FN2O2/c1-24(2)15-21(20-5-3-4-6-22(20)29-24)26-23(28)18-11-13-27(14-12-18)16-17-7-9-19(25)10-8-17/h3-10,18,21H,11-16H2,1-2H3,(H,26,28)/t21-/m0/s1

InChI Key

CFRHQJZJJOMPRM-NRFANRHFSA-N

MDL Number (MFCD)

MFCD19027850

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

396.5

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

3.506

Distribution Coefficient, logD

1.312

Water Solubility, LogSw

-3.67

Polar Surface Area

34.640

Acid Dissociation Constant (pKa)

11.13

Base Dissociation Constant (pKb)

9.59

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

45.80

Y300-0171 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

CORONAVIRUS Library (20774 compounds)

GPCR Targeted Library (31838 compounds)

PLpro Library (6343 compounds)

PD-1/L1 Library (498 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
Targets:
  • GPCR
  • Others
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with Y300-0171 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y300-0171?
Check Price and Availability of Y300-0171, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y300-0171 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y300-0171
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y300-0171
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y300-0171 available by request